Sterile Processing Services of America

Instrumentum addresses the capacity mismatch between growing surgical programs and static internal sterile processing departments. When OR expansion outpaces SPD capacity, hospitals face a forced choice between expensive infrastructure projects and capping surgical volume. Instrumentum offloads tray sterilization to its own facilities, stabilizing throughput without multi-year capital builds.

The firm invests directly in physical sterilization infrastructure—facilities it owns and operates—rather than acting as a financial investor in third-party operating companies. Its model is closer to an infrastructure owner-operator serving the healthcare sector than a traditional private equity approach.

The firm does not publicly name its founders, managing principals, or investment committee on its website or in available primary sources. The operational identity is fully subsumed under the Instrumentum brand.

Pricing structures are not disclosed. The model is described as outsourced infrastructure that integrates into a hospital's existing logistics, implying a contractual, recurring revenue arrangement aligned with surgical case volume rather than one-time capital payments.

There is no evidence of a co-investment posture or fund commitments. The entity appears structured as a direct owner-operator of physical assets, without disclosed relationships to external general partners or LP-led investment vehicles.